Industry Members
ReNeuron Group plc
ReNeuron is a leading, clinical-stage stem cell business. Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
ReNeuron’s lead candidate is the ReN001 stem cell therapy for the treatment of stroke. We are also developing stem cell therapies for other conditions such as peripheral arterial disease and blindness-causing diseases of the retina.
ReNeuron have also developed a stem cell lines for non-therapeutic applications – ReNcellŪCX and ReNcellŪVM neural cell lines are marketed worldwide under license by Merck Millipore.
Address:
10 Nugent Road
Surrey Research Park
Guildford
GU2 7AF
UK
Tel: +44 (0)1483 302560
Email:
info@reneuron.com
Website:
http://www.reneuron.com
